Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Lymphoma, Non-Hodgkin 5Leukemia, Myeloid, Acute 5Hodgkin Disease 5Anemia, Refractory, with Excess of Blasts 5Multiple Myeloma 4Leukemia, Myeloid, Chronic-Phase 4Blast Crisis 4Waldenstrom Macroglobulinemia 3Primary Myelofibrosis 3Myeloproliferative Disorders 3Myelodysplastic Syndromes 3Leukemia, Myelomonocytic, Chronic 3Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3Leukemia, Lymphocytic, Chronic, B-Cell 3Hematologic Neoplasms 3Myelodysplastic-Myeloproliferative Diseases 2Lymphoma, Mantle-Cell 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma 2Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 2Leukemia, Myeloid, Accelerated Phase 2Graft vs Host Disease 2Congenital Abnormalities 2Anemia, Aplastic 2Tufted angioma 1Thrombocytosis 1Thrombocytopenia 1Thrombocythemia, Essential 1Sezary Syndrome 1

Interventions

Sirolimus 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphangioma × Sirolimus × Classical hematology × Clear all
NCT00975819 2026-01-06

Safety and Efficacy Study of Sirolimus in Complicated Vascular Anomalies

Boston Children's Hospital

Phase 2 Completed
61 enrolled 7 charts
Classical hematology

Tufted angioma, Lymphangioma, Thrombocytopenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡